Alkem Laboratories Ltd. (ALKEM) Laboratories Share Price: Stock trades near 52-week low on weak momentum
- September 30, 2026
- Posted by: Chaitanya Auti
- Category: News
Alkem Laboratories Share Price is trading at Rs 5,009.5, up 0.29% from the previous close, while still near its 52-week low at 21 October 2026 at 9:23 AM IST. The company’s market capitalisation stands at Rs 59,722.72 crore, keeping Alkem Laboratories Ltd. (ALKEM) firmly on investor screens even as the latest Univest data confirms a one-year low zone rather than a company-specific catalyst. Alkem Laboratories Share Price Today is relevant because the stock is moving close to its yearly low while the broader context remains driven by price action, sector positioning and valuation. For investors tracking Alkem Laboratories Stock News, the immediate question is not only what the share price is doing, but how far it remains below its short- and medium-term trend markers.
At the latest mark, Alkem Laboratories Share Price moved between Rs 4,964.05 and Rs 5,010 during the day, after opening at Rs 4,964.05 against a previous close of Rs 4,995. The stock is therefore holding just above the day’s opening level and near its intraday high, which indicates that the early selling pressure was partly absorbed. Even so, the price structure still places Alkem Laboratories Share Price in a near 52-week low band, a setup that often attracts stock analysis searches around support level, price action and stocks at 52 week low. The latest move does not establish a company-specific trigger, so the focus stays on verified market data, sector comparison and financial quality.
Alkem Laboratories Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 5,009.5 |
| Previous Close | Rs 4,995 |
| Today's Move | +Rs 14.5 (+0.29%) |
| Open | Rs 4,964.05 |
| High | Rs 5,010 |
| Low | Rs 4,964.05 |
| Market Capitalisation | Rs 59,722.72 crore |
Alkem Laboratories Ltd. (ALKEM) traded at Rs 5,009.5 versus the previous close of Rs 4,995, a rise of 0.29%. The stock opened at Rs 4,964.05, reached a high of Rs 5,010, touched a low of Rs 4,964.05.
Alkem Laboratories Share Price Today shows a mild intraday gain, but the larger takeaway is the stock’s placement close to its 52-week low. The share price is Rs 5,009.5 after a change of Rs 14.5, or 0.29%, versus the previous close of Rs 4,995. The day open was Rs 4,964.05, the day high was Rs 5,010 and the day low was Rs 4,964.05. That range shows the stock moving in a tight band, with the session starting at the low and recovering toward the top of the band. Alkem Laboratories Share Price News is therefore less about a sharp breakout and more about whether the current price can stabilise above the immediate support area defined by recent price action.
The market capitalisation of Rs 59,722.72 crore keeps Alkem Laboratories Share Price in the large-cap healthcare universe. For traders watching Stock Market Today and Share Market Today trends, the key point is that the stock is not falling sharply in this moment, yet it remains near a one-year low and in the list of Stocks in News for that reason. This is why Alkem Laboratories Share Price Update matters: the current move shows cautious stability, but not a clear shift away from the low zone. The near-52-week-low setup also makes this one of the 52 Week Low Stocks being tracked for price action rather than a fresh catalyst. That context leads directly into a closer look at Alkem Laboratories Technical Analysis.
One-sentence takeaway: Alkem Laboratories Share Price is holding a modest intraday gain, but the broader pattern still points to pressure around the yearly low area rather than a decisive recovery.
Alkem Laboratories Ltd. (ALKEM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 59,722.72 crore |
| P/E Ratio | 27.68x |
| P/B Ratio | 4.17x |
| ROE | 18.29% |
| ROCE | 21.28% |
| EPS | Rs 180.45 |
| Book Value Per Share | Rs 1,196.51 |
| Dividend Yield | 1.06% |
Alkem Laboratories Ltd. (ALKEM) fundamental metrics show P/E 27.68x, P/B 4.17x, ROE 18.29%, ROCE 21.28%. These figures provide context only and are not a buy or sell signal.
Alkem Laboratories Ltd. has a market capitalisation of Rs 59,722.72 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 27.68x, P/B at 4.17x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 18.29% and ROCE of 21.28%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 180.45, book value per share of Rs 1,196.51, dividend yield of 1.06%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 26.67x, median ROE of 11.23%, median ROCE of 13.17%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 27.68x |
| Benchmark Median P/E | 26.67x |
| Benchmark Average P/E | 39.34x |
| Benchmark P/E Range | 0x to 616.89x |
| Company P/B Ratio | 4.17x |
| Benchmark Median P/B | 2.74x |
| Company ROE | 18.29% |
| Benchmark Median ROE | 11.23% |
| Company ROCE | 21.28% |
| Benchmark Median ROCE | 13.17% |
| Company Market Capitalisation | Rs 59,722.72 crore |
| Benchmark Median Market Cap | Rs 768.75 crore |
Alkem Laboratories Ltd. (ALKEM) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Alkem Laboratories Ltd. (ALKEM) has a P/E ratio of 27.68x, which is above the benchmark median of 26.67x, a difference of +3.79%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Alkem Laboratories Ltd. (ALKEM) has a ROE of 18.29%, which is above the benchmark median of 11.23%, a difference of +62.87%. Alkem Laboratories Ltd. (ALKEM) has a ROCE of 21.28%, which is above the benchmark median of 13.17%, a difference of +61.58%.
Track stocks falling to yearly lows through the Univest 52-week-low screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Glenmark Pharmaceuticals Ltd. | GLENMARK | 62,339.2 | 34.67 | 5.69 | 14.1 | 20.35 |
| Biocon Ltd. | BIOCON | 55,491.09 | 112.04 | 1.63 | 1.35 | 3.26 |
| Abbott India Ltd. | ABBOTINDIA | 54,909.79 | 34.01 | 10.61 | 34.67 | 46.72 |
| Gland Pharma Ltd. | GLAND | 49,952.91 | 44.25 | 4.7 | 10.56 | 14.96 |
| Ipca Laboratories Ltd. | IPCALAB | 46,049.85 | 35.16 | 5.43 | 15.88 | 19.41 |
Alkem Laboratories Ltd. (ALKEM) has a P/E ratio of 27.68x compared with the displayed peer median of 35.16x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 18.29% compares with a peer median of 14.1% across the companies shown in the table. ROCE stood at 21.28% versus the displayed peer median of 19.41%, providing a capital-efficiency comparison. Alkem Laboratories Ltd. (ALKEM) has a market capitalisation of Rs 59,722.72 crore. Among the 5 peers shown, only 1 has a larger market capitalisation.
Why Investors Are Watching Alkem Laboratories
- Alkem Laboratories Share Price is near its 52-week low, so price action remains the first point of interest.
- The stock is trading with a modest intraday gain, but still in a one-year low zone.
- ROE of 18.29% and ROCE of 21.28% support the company’s fundamental profile.
- P/E of 27.68 and P/B of 4.17 keep valuation in focus versus the sector benchmark.
- Market capitalisation of Rs 59,722.72 crore makes it a significant name in Healthcare and Pharmaceuticals & Drugs.
About Alkem Laboratories
Alkem Laboratories Ltd. operates in the Pharmaceuticals & Drugs industry within the Healthcare sector. The company is part of the Indian listed pharmaceutical universe and is tracked on both NSE and BSE as ALKEM. Its financial profile shows a large market capitalisation, a meaningful earnings base and a book value per share of Rs 1,196.51, which helps frame Alkem Laboratories Share Price in a broader company-overview context.
The latest revenue figure available is Rs 3,740.15 crore for Jun 2026, showing the scale of its operating business. Investors typically track Alkem Laboratories Stock News and Alkem Laboratories Company News for a combination of earnings quality, margin trends and market valuation. The current data set supports a view of a sizeable healthcare business with profitability metrics that sit above the median of its industry peer group. That is why Alkem Laboratories Share Price remains important for stock analysis even while the market price is near a yearly low. In practical terms, the company’s profile is best understood through its financial results, peer position and the way the market is pricing those fundamentals.
Track Alkem Laboratories Share Price on Univest
Use Alkem Laboratories Ltd. (ALKEM) live share-price page, Univest 52-week-low screener, Univest market blogs to review live stock data, yearly-low lists and related market analysis.
Investors can track Alkem Laboratories Share Price on Univest for live price updates, technical indicators, valuation ratios, shareholding pattern, 52-week levels and market insights. Univest also helps readers compare Alkem Laboratories Share Price Today with sector peers, check Alkem Laboratories Fundamental Analysis and follow new Alkem Laboratories Latest News in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.
Frequently Asked Questions
Why is Alkem Laboratories Share Price near a 52-week low?
Ans. Alkem Laboratories Share Price is near a 52-week low because the stock is trading close to its yearly trough zone. The latest Univest data confirms the price event, but it does not establish a company-specific catalyst.
What is Alkem Laboratories Share Price today?
Ans. Alkem Laboratories Share Price is Rs 5,009.5, up 0.29% from the previous close of Rs 4,995. The move keeps the stock near its one-year low while preserving a modest intraday gain.
How much did Alkem Laboratories share move today?
Ans. Alkem Laboratories Share Price moved by Rs 14.5 during the day, equal to 0.29%. It opened at Rs 4,964.05 and touched a high of Rs 5,010, indicating a tight trading range.
What does the market cap of Alkem Laboratories show?
Ans. The market capitalisation is Rs 59,722.72 crore. Market cap measures company size, not quality, but it helps place Alkem Laboratories Share Price among large healthcare names in the Indian listed universe.
Is Alkem Laboratories expensive based on valuation?
Ans. Alkem Laboratories trades at a P/E of 27.68 and a P/B of 4.17. That is slightly above the industry median P/E and above the median P/B, but the return ratios remain stronger than the benchmark.
What do ROE and ROCE mean for Alkem Laboratories?
Ans. ROE is 18.29% and ROCE is 21.28%. ROE measures return on shareholder equity, while ROCE measures returns generated on capital employed, both indicating efficient use of capital. ROE stands at 18.29%.
What is Alkem Laboratories EPS and book value?
Ans. EPS is Rs 180.45 and book value per share is Rs 1,196.51. EPS reflects earnings per share, while book value shows accounting net worth behind each share, both useful in stock analysis.
What is the dividend yield for Alkem Laboratories Share Price?
Ans. Dividend yield stands at 1.06%. This is historical current data, not a guarantee of future payout, but it remains relevant for investors comparing Alkem Laboratories Share Price with other healthcare stocks.
How does Alkem Laboratories compare with peers?
Ans. Compared with peers such as Glenmark, Biocon, Abbott India, Gland Pharma and Ipca Laboratories, Alkem Laboratories sits near the middle on valuation, while its ROE and ROCE are stronger than several listed rivals.
What should investors track next in Alkem Laboratories Stock News?
Ans. Investors should track whether Alkem Laboratories Share Price holds above the current low zone, how it behaves against its 50 DMA of Rs 5,235.64 and 200 DMA of Rs 5,385.07, and whether sector valuation remains supportive.